NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 155 filers reported holding NPS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $64,801,000 | +3.3% | 1,811,609 | -24.9% | 0.05% | +1.9% |
Q3 2014 | $62,712,000 | -31.0% | 2,412,013 | -12.3% | 0.05% | -31.2% |
Q2 2014 | $90,937,000 | +21.7% | 2,751,488 | +10.2% | 0.08% | +18.5% |
Q1 2014 | $74,713,000 | +11.6% | 2,496,246 | +13.2% | 0.06% | +8.3% |
Q4 2013 | $66,922,000 | +306.7% | 2,204,276 | +326.1% | 0.06% | +275.0% |
Q3 2013 | $16,456,000 | +455.6% | 517,332 | +163.7% | 0.02% | +433.3% |
Q2 2013 | $2,962,000 | – | 196,158 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 431,475 | $15,433,000 | 5.92% |
SECTORAL ASSET MANAGEMENT INC | 1,623,073 | $58,057,000 | 2.60% |
Palo Alto Investors LP | 1,190,263 | $42,576,000 | 2.50% |
Fiera Capital (Europe) Ltd. | 426,250 | $3,246,000 | 2.39% |
BENDER ROBERT & ASSOCIATES | 75,080 | $2,686,000 | 1.76% |
FCG ADVISORS, LLC | 76,865 | $3,138,000 | 1.55% |
Penn Capital Management Company, LLC | 857,621 | $30,677,000 | 1.29% |
NEXT CENTURY GROWTH INVESTORS LLC | 927,285 | $33,168,000 | 1.20% |
Tekla Capital Management LLC | 625,900 | $22,388,000 | 1.05% |
Orbimed Advisors | 2,954,900 | $105,697,000 | 1.01% |